Clinical Trials Directory

Trials / Conditions / Non-Hodgkin's Lymphoma Refractory

Non-Hodgkin's Lymphoma Refractory

7 registered clinical trials studyying Non-Hodgkin's Lymphoma Refractory — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingSafety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL a
NCT05779930
Nationwide Children's HospitalEARLY_Phase 1
RecruitingTR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors
NCT05650580
Tarapeutics Science Inc.Phase 1
Active Not RecruitingA Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma
NCT05574114
Memorial Sloan Kettering Cancer CenterPhase 1
RecruitingCART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Ly
NCT05054257
Institute of Hematology and Blood Transfusion, Czech RepublicPhase 1
TerminatedRPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies
NCT04844086
Eden BioCell Ltd.Phase 1
RecruitingCAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignan
NCT04603872
Zhejiang UniversityEARLY_Phase 1
CompletedDose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL
NCT04030195
Precision BioSciences, Inc.Phase 1 / Phase 2